Bruce J MacLachlan

9PUBLICATIONS
28CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 02, 2024
The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32.

Phillip Pymm, Philippa M Saunders, Sushma Anand

|Apr 03, 2024
Unconventional modes of peptide-HLA-I presentation change the rules of TCR engagement.

Jade R Hopkins, Bruce J MacLachlan, Stephen Harper

|Mar 10, 2022
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan

|Apr 13, 2021
Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.

Shoeib Moradi, Sanda Stankovic, Geraldine M O'Connor

|Jan 14, 2021
The Role of the HLA Class I α2 Helix in Determining Ligand Hierarchy for the Killer Cell Ig-like Receptor 3DL1.

Philippa M Saunders, Bruce J MacLachlan, Jacqueline Widjaja

|Sep 13, 2020
Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor.

Bruce J MacLachlan, Georgina H Mason, Alexander Greenshields-Watson

Pageof 2